All posts
Alzheimer's
ANVISA
Author: Allan Matsui
Author: Jairo Utimi
Author: Claudia Cilento
Author: Nilva Bortoleto
BPF
Cannabidiol
Cancer
Cannabis
Coronavirus
Covid-19
challenges
Epilepsy
pharmaceutical
IFA
pharmaceutical industry
Inovatie
medicines
opportunities
Parkinson
pharmaceuticals
pharmaceutical industry
Author: Camille Rodrigues da Silva
Incremental innovation
Investments
Marketing
News
Incremental innovation
Good Manufacturing Practices
Search
Feb 9, 2021
What is the purpose of clinical research on health products?
Feb 9, 2021
What are the new expectations for the development of incremental products and medicines?
Feb 9, 2021
Clinical studies for health devices: 5 value tips
Feb 9, 2021
DDCM: what are the points that generate the most demands at ANVISA (Part 2)?
Feb 9, 2021
The biotechnological challenge of the national pharmaceutical industry has already begun
Feb 9, 2021
New Efficacy and Safety Analysis Roadmap for Synthetic Drug Registration
E-BOOKS
CONTEÚDOS EXCLUSIVOS PARA AUXILIAR EM
SEU TRABALHO
Acesse
